透明质酸水凝胶作为乳腺癌保乳治疗瘤床标志物的应用
本研究评估透明质酸(HA)水凝胶作为乳腺癌保乳治疗(BCT)瘤床标志物的价值,分析外照射放疗(EBRT)中推量靶区(CTVboost)勾画的观察者间和观察者内变异性。三维放射肿瘤学家对每位患者勾画CTVboost两次,计算体积变异系数(COVV)、质心位移(CoMd)和一致性指数(CI)。结果显示HA组与对照组COVV均值无显著差异,但HA组CoMd更小、CI更高,表明HA水凝胶改善瘤床可见性并减少勾画变异性。
要点
- HA水凝胶组观察者间质心位移均值6.1 mm,对照组9.1 mm。
- HA水凝胶组观察者间一致性指数均值0.56,对照组0.47。
- HA水凝胶未显著改变体积变异系数,但改善瘤床可见性和勾画一致性。
核心结论
- HA水凝胶作为瘤床标志物可改善瘤床可见性,并减少EBRT推量靶区勾画的观察者间和观察者内变异性。
研究设计与样本
- 三位放射肿瘤学家对每位患者勾画CTVboost两次,计算COVV、CoMd和CI量化勾画变异性。
主要发现
- HA组与对照组COVV均值无显著差异:观察者内0.14 vs 0.13,观察者间0.19 vs 0.18。
- 观察者间CoMd均值HA组6.1 mm,对照组9.1 mm;观察者内CoMd均值HA组3.9 mm,对照组6.4 mm。
- 观察者内CI均值从对照组0.61改善至HA组0.65;观察者间CI均值从对照组0.47改善至HA组0.56。
临床怎么用
- 在乳腺癌保乳治疗中,可考虑术中注射HA水凝胶标记瘤床,以改善EBRT推量靶区勾画的观察者间和观察者内一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate usefulness of hyaluronic acid (HA) hydrogel as a tumour bed marker in breast conserving therapy (BCT). To analyze inter- (Inter-OV) and intraobserver (Intra-OV) variability of contouring boost target volume (CTVboost) in external beam radiotherapy (EBRT). MATERIALS AND METHODS: Thirty-two patients in the HA group and 30 patients in the control group with an early stage breast cancer were included in the study. During the surgery 1-3 ml of HA hydrogel was injected into breast to mark the tumour bed for every patient in the HA group. Moreover, surgical clips were placed underneath the lumpectomy cavity. Patients in the control group were marked only by metal markers. Three radiation oncologists delineated CTVboost twice for every patient. Three parameters were calculated to quantify contouring variability: coefficient of variation for volumes (COVV), center of mass displacement (CoMd) and conformity index (CI). RESULTS: There were no significant differences between mean values of COVV for HA and control group, neither for Intra-OV (0.14 vs 0.13) nor Inter-OV (0.19 vs 0.18) calculations. The mean CoMd were 6.1 mm and 9.1 mm for Inter-OV calculations and 3.9 mm and 6.4 mm for Intra-OV in the HA and the control group respectively. The mean CI for Intra-OV improved from 0.61 to 0.65 and from 0.47 to 0.56 for Inter-OV in the control and HA group respectively. CONCLUSION: HA hydrogel used as a tumour bed marker improves tumour bed visibility and reduces inter- and intraobserver variability of EBRT boost target volume delineations.
引用
- Wiercińska J, Winiecki J, Wronczewska A, et al. The use of hyaluronic acid hydrogel as a tumour bed marker in breast-conserving therapy. Radiother Oncol. 2020. PMID: 32738260. doi:10.1016/j.radonc.2020.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。